For the quarter ending 2026-03-31, MC had -$355,627K decrease in cash & cash equivalents over the period. -$291,588K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 42,295 | 99,016 | 60,071 | 100,530 |
| Bad debt expense (benefit) | 892 | -265 | 768 | 236 |
| Depreciation and amortization | 3,493 | 3,364 | 2,976 | 5,539 |
| Equity-based compensation | 72,208 | 62,252 | 40,166 | 127,843 |
| Deferred tax provision (benefit) | 3,866 | 21,371 | 21,996 | 6,662 |
| Gain on partial sale of equity method investment | - | 0 | 19,092 | - |
| Other | 198 | 1,514 | 10,898 | 845 |
| Accounts receivable | 16,929 | 26,576 | 1,131 | 3,529 |
| Accrued and other receivables | -347 | -16,333 | -1,921 | 23,771 |
| Prepaid expenses and other assets | 177 | 1,402 | 6,394 | 1,070 |
| Deferred compensation | 26,050 | 958 | -4,913 | 17,491 |
| Compensation payable | -374,647 | 145,674 | 104,012 | -158,436 |
| Accounts payable, accrued expenses and other liabilities | 16,061 | 15,616 | 2,708 | -90 |
| Deferred revenue | -1,295 | 5,832 | -3,873 | 1,486 |
| Dividends received from equity method investment | 1,336 | 0 | 724 | 1,623 |
| Net cash provided by (used in) operating activities | -278,798 | 338,743 | 198,867 | 38,687 |
| Purchases of investments | 201,712 | 116,231 | 151,786 | 256,737 |
| Proceeds from sales of investments | 341,182 | 116,393 | 68,000 | 151,398 |
| Note payments (issued to) employees | 3,295 | 845 | - | - |
| Note payments received from (issued to) employees | - | - | 0 | 138 |
| Note payments received from employees | 4,218 | 250 | - | - |
| Proceeds from partial sale of equity method investment | - | 0 | 29,916 | - |
| Purchases of equipment and leasehold improvements | 12,790 | 9,159 | 19,315 | 7,856 |
| Net cash provided by (used in) investing activities | 127,603 | -9,730 | -73,185 | -113,057 |
| Payments for dividends and tax distributions | 54,942 | 53,094 | 51,397 | 104,212 |
| Payments for treasury stock purchases | 117,270 | 46,123 | 15,198 | 13,270 |
| Payments under tax receivable agreement | 32,206 | 0 | 0 | 314 |
| Other distributions | - | -288 | - | - |
| Net cash provided by (used in) financing activities | -204,418 | -99,505 | -66,595 | -117,796 |
| Effect of exchange rate fluctuations on cash, cash equivalents, and restricted cash | -14 | -2,578 | 832 | 1,503 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -355,627 | 226,930 | 59,919 | -190,663 |
| Cash, cash equivalents, and restricted cash, beginning of period | 509,365 | 282,435 | 413,179 | - |
| Cash, cash equivalents, and restricted cash, end of period | 153,738 | 509,365 | 282,435 | - |
Moelis & Co (MC)
Moelis & Co (MC)